Carey Thomas D. bought LAB
June 18, 2026 · Form 4 insider transaction
Carey Thomas D. bought 263,884 shares of Standard BioTools Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
263,884
Price
$0.00
Total value
N/A
InsiderCarey Thomas D.
RoleDirector
CompanyStandard BioTools Inc. (LAB)
SecurityStock Option (Right to buy)
Transaction codeA: Grant or award
Transaction dateJune 18, 2026
Filing dateJune 23, 2026
Shares owned after263,884
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date.